Navigation Links
Food Ingredients Industry Leaders Applaud the Launch of Health ingredients South America
Date:6/30/2009

The event was an unmitigated success, welcoming 1012 visitors who left the show impressed and vowing to return in 2011.

SAO PAULO, June 30 /PRNewswire/ -- A total success. That sums up the Health ingredients (Hi) South America Summit, held for the first time on June 15-16, 2009 at Sao Paulo's Novotel Centre Norte. The international conference and tabletop exhibition welcomed over 1000 key decision-makers in the food industry, in this, its inaugural edition.

The Summit's organizer, UBM Brazil, reports that 323 of the visitors attended the conference program, which consisted of more than 45 presentations on a full range of business crucial industry subjects, including obesity, micro-encapsulation, cosmoceuticals, cardiovascular health, brain health, sporting nutrition, diabetes, and market conditions.

"There was not one word of negative comment on the event, showing that it satisfied both visitors and exhibitors," says United Business Media Events Manager Vincent Brain, who is responsible for UBM's Health ingredient events outside Europe. "Hi South America shows that the functional ingredients sector is highly dynamic. This dynamism presents a major continuing challenge for the professionals involved in marketing, and research and development for companies. That is why this event was so successful. It was an open forum for exhibitors to launch their products and innovations, the objective of which is to improve the health of end consumers."

The South American version has now established itself as the meeting point in Brazil for functional food ingredient companies, as witnessed by participants' comments that the results exceeded their expectations.

"Our participation in Hi South America was very beneficial and interesting, since we want to attract new clients in Brazil, by presenting our product PreB-Florane
'/>"/>

SOURCE Health ingredients
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Solae Announces Global Price Increase for Soy Protein Ingredients
2. New ingredients in drug-like anti-aging products improve skin
3. The Ultimate Valentines Day Gift: Indulgent Organic Chocolate for Women That Combines Great Taste & Functional Ingredients
4. Tea Ingredients Publication Serves Robust Global Demand for Tea-Based Products
5. Answers From Nature Introduces 100% Non-China Ingredients for Dietary Supplements
6. CMP is Back This Year with Loads of Innovative Ideas and Varieties of Food Ingredients
7. The secret ingredients behind germinated rice
8. Gencor Pacific Group Picks Up Frost & Sullivan Global Appetite Suppressant and Satiety Ingredients Product Innovation of the Year Award
9. Schiff(R) Melatonin Plus Passes ConsumerLab.com Test for Ingredients and Product Quality
10. Fishing for Opportunities in the Omega-3 Ingredients Market
11. Growth in the Functional Food Sector Gives a Hearty Boost to the Heart Health Ingredients Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... survey of Fortune 1000 employers strongly indicates that wellness programs ... benefits. , ... Minneapolis, MN (PRWEB) ... companies reveals that 78 percent of employers have improved employee ... program. In the survey, conducted by Hallmark Insights, ...
(Date:12/16/2009)... Dec. 16 Tyco International Ltd. (NYSE: ... of Michael E. Daniels for election to the ... General Meeting on March 10, 2010. ,, ... Global Technology Services group of International Business Machines ... for IBM,s Global Services business operations consisting of ...
(Date:12/16/2009)... 16 Dale Buchanan, owner of Supreme Ultimate ... a weight loss contest for his students in the new ... are not competing for their own prize or against each ... the Tri County Humane Society in Boca Raton, ... loses between January 4 and February 28, 2010 I will ...
(Date:12/16/2009)... Study finds 6- to 11-month interval lessens complication risks , , ... bundle of joy has had such a profound impact on ... take a breath. A new study suggests that you ... pregnant again, and that more than 11 months could be ... interval between pregnancies was less than six months, the chances ...
(Date:12/16/2009)... received a further 1.6 million Euro in capital funding to ... in order to meet the rapidly growing demand for this promising ... A/S that continue to own each about 50% of the company. ... ... Unisense FertiliTech A/S has received a further 1.6 million Euro ...
Breaking Medicine News(10 mins):Health News:Hallmark Insights' Employer Survey Reveals Cost-Savings Benefits of Health & Wellness Programs 2Health News:Tyco International Files Preliminary Proxy Proposing Election of New Director 2Health News:Fitness Trainer Motivates Clients with Weight Loss to Help Raise Money for Animal Shelter 2Health News:For Babies' Sake, Pregnancy Spacing Matters 2Health News:For Babies' Sake, Pregnancy Spacing Matters 3Health News:Increased Capital Funding for Unisense FertiliTech A/S Will Help Meet Demand for New Assisted Reproduction Device 2
... that millions of newborn babies, //children and mothers die each ... of better healthcare by governments and donor countries. ... the health situation in several countries has not improved in ... ,According to the WHO African countries accounted for 19 of ...
... Canadian cities reveals that the legal prescription drugs such ... heroin, raising questions about drug control in the country. ... or prescription painkillers are at increasing rate though heroin ... Canada for years. ,Dr. Benedikt Fischer, a ...
... its readiness to increase its health sector cooperation with ... products. ,"We hope to enhance cooperation in the ... and doctors' exchange programmes," Hamad bin Abdullah Al-Manie, the ... ,Al-Manie, who is currently in India, was speaking at ...
... are holiday traditions, but UT Southwestern Medical Center experts warn ... for the 6 million Americans who have diabetes and don’t ... obesity, can be a silent killer because its symptoms aren’t ... disease or other maladies. ,That’s bad news for ...
... A New survey reveals that majority of doctors' fail in ... problems. //Four in five GPs are not able to correctly ... can pose a risk to long-term health. ,The ... taskforce Act Against Allergy and is sponsored by SHS International. ...
... practitioners need better resources and support to care for ... researchers. // ,In an editorial for ... general practice and family health specialists have outlined new ... in which partner violence is occurring. ...
Other Medicine News:Health News:WHO Attributes Death of Millions in Africa to Treatable diseases 2Health News:Prescription Opioids Abused More Than Heroin - A Report Says 2Health News:Holiday Gluttony Can Spell Disaster for Undiagnosed Diabetics 2Health News:Majority Of Doctors Tend To Ignore Milk Allergy Cases In Babies 2Health News:Tackling Violence in Families 2
(Date:12/16/2009)... Dec. 16 Savara, Inc., an inhalation drug ... second tranche in its Series A financing round, exceeding ... ,, Funds raised in the Series A round ... NanoCluster technology. ,, "We now have the runway ... of the NanoCluster technology," said Rob Neville, CEO of ...
(Date:12/16/2009)... Dec. 16 ChemoCentryx, Inc. today announced ... Phase 2 clinical trial of CCX354, an orally-bioavailable, ... the CCR1 chemokine receptor for the treatment of ... highly potent and selective antagonist of CCR1, a ... cells, such as monocytes and macrophages, associated with ...
(Date:12/16/2009)... -- , - ... a Total of Over,640 patients Ahead of ... NV (Euronext Brussels: THR), a biopharmaceutical company,focused ... treatments for eye,disease, vascular disease and cancer, ... of the second Phase III trial evaluating ...
Breaking Medicine Technology:Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent 2ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 2ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 3ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 4ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 5ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 2ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 3ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 4Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 1Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 2Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 3Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 4Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 5Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 6Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 7Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 8Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 9Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 10Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 11Finding a protective mechanism for retinal cells could save sight 14859 1Finding a protective mechanism for retinal cells could save sight 14859 2Bacterial ropes tie down shifting Southwest 10753 1Bacterial ropes tie down shifting Southwest 10753 2
... is an urgent need for more,comprehensive lipid control to ... A new 30-year analysis of the,National Health and ... Association (NLA) indicates that while,Americans are doing a better ... adults with high triglycerides, a blood fat linked to ...
... Data from an investigational,open-label, randomized study assessing ... treating anemia in subjects with Stages 3 ... today at the American Society,of Nephrology 41st ... including the FDA-approved,three-times-per-week (TIW) regimen, plus once-a-week ...
Other Medicine Technology:New Analysis Shows Troubling Trend in Triglyceride Levels May Be Linked to Rising Rates of Obesity 2New Analysis Shows Troubling Trend in Triglyceride Levels May Be Linked to Rising Rates of Obesity 3Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 2Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 3Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 4Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 5Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 6
The Bio-Quant TROPONIN I test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of cardiac,troponin I (cTnI) in human serum specimens as an aid i...
... InstaTest IgE test kit is an immunochromatographic ... levels of immunoglobulin E in human serum ... commonly associated with allergic pathologies. It may ... some infections. Rapid detection of IgE using ...
... is an all new, completely re-engineered high performance ... LOWEST CROSSING PROFILE PTCA products available ... profile of only 0.17. Atriums all new HyperLite ... catheter ever!, ,Atriums new "Dura-Blend tip technology is ...
... The Veris physiological monitor offers a ... those specifically designed for pediatric and neonate ... up to 3T. Veris is the first ... needs of pediatric and neonate patient monitoring. ...
Medicine Products: